Strategies to Reduce the Osteoporosis Treatment Gap
Long Term Osteoporosis Therapies: Drug Interruption and Monitoring
Friday, May 8, 2020
2:50 PM – 3:30 PM
Participants should be aware of the following financial/non-financial relationships: Ghada Fuleihan, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Assess the Evidence on Fracture Risk Reduction with Long-Term Therapy
Determine Predictors of Fracture Incidence Off Therapy